Michael R. Berman
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael R. Berman.
Current Eye Research | 1991
Ken Hayashi; Michael R. Berman; Don Smith; Aly El-ghatit; Steven Pease; Kenneth R. Kenyon
Previous studies have suggested that the plasminogen activator (PA)/plasmin system has important roles in the pathogenesis of epithelial defects and stromal ulceration. The current studies were performed to localize PA species and identify them as tissue-type PA (tPA) or urokinase-like PA (uPA) as the two have distinct regulatory properties potentially related to the mechanisms of defect formation and ulceration. To determine the locations and types of PA species, antibodies to tPA or to uPA or the drug amiloride (a drug that inhibits uPA but not tPA) were incorporated into fibrin/fibronectin (Fn) clots overlying frozen sections to block regional fibrinolysis. Normal rabbit eyes showed tPA activity in association with corneal epithelium, corneal endothelium, and ciliary body/iris. After epithelial scrape or alkali burn, corneal tPA activity was detected initially in the defect zone colinear with fibrin/Fn and was symmetrical to resurfacing epithelium. The observation that initial fibrinolysis occurs in the defect zone, known to contain fibrin/Fn, suggests that tPA from blood (limbal vascular endothelium) and/or from corneal epithelium has become bound to (and activated on) the fibrin/Fn. PA activity was also associated with the leading edges of migrating epithelium post-scrape and post-burn and was not inhibited by antibodies to either tPA or uPA but was inhibited by amiloride. After complete closure of the primary defect post-scrape, only tPA appeared to be associated with the epithelium in that all PA activity was inhibited by antibodies to tPA. The observation that leading edge activity post-burn, in correlation with the formation of secondary defects, continues to be inhibitable by amiloride but not by antibodies to tPA suggests that uPA remains abnormally on the leading edge, and that sustained uPA activity in that location results in inappropriate degradation of subepithelial fibrin/Fn to result in a defect. Successful regulation of uPA activity at the leading edge of corneal epithelium post-burn would be expected to be useful therapeutically in the healing of epithelial defects and the prevention of stromal ulceration.
Journal of Molecular and Cellular Cardiology | 1988
Michael R. Berman; Jon N. Peterson; David T. Yue
To determine whether catecholamines produce alterations in myocardial myosin-actin cycling kinetics, we investigated the effects of isoproterenol upon mechanical characteristics of constantly activated heart muscle thought to reflect crossbridge behavior. In isolated rabbit right ventricular papillary muscles in barium contracture at 24 degrees C, we found that 10 microM isoproterenol caused: (a) a 23% reduction of the 10 to 90% rise time of slow tension recovery in force transients induced by rapid, small amplitude stretches; and (b) a 23% increase in the frequency of sinusoidal length perturbation at which stiffness amplitude exhibited a minimum. Based upon previous mechanistic interpretations of force transients, and on an analysis developed here to relate crossbridge events to the frequency-dependence of stiffness, we argue that our observations provide evidence that isoproterenol induces an acceleration of crossbridge cycling rate. This raises the intriguing prospect that beta-adrenergic stimulation regulates contraction, not only by well-known alterations in calcium metabolism, but also by intrinsic modulation of the force-generating machinery itself.
Anesthesiology | 1989
Ok Yung Chung; Thomas J. J. Blanck; Michael R. Berman
The authors examined the effects of nifedipine, a sarcolemmal slow Ca2+ channel blocker, on dynamic stiffness and force of rabbit right ventricular trabeculum and papillary muscle in Ba2+ contracture, in an attempt to reproduce the effects of halothane, enflurane, and isoflurane on a similar preparation as reported by Shibata et al. Once barium contracture force was established, muscle length was perturbed with small amplitude sinusoidal oscillations in the frequency range of 0.1-100 Hz. Nifedipine 1 microM was then added to the superfusate and dynamic stiffness was again measured. Additional barium was used to determine restoration of contracture force to and beyond control levels. Nifedipine produced a significant decrease in contracture force and high-frequency stiffness with no effect on the frequency (fmin) at which stiffness amplitude exhibited a minimum (P less than 0.005). Contracture force and stiffness could be restored by adding additional barium to the nifedipine-treated muscles. These results are similar to those reported by Shibata et al. using volatile anesthetics. Since nifedipine, which acts specifically at the sarcolemmal slow Ca2+ channel, affects contracture force and dynamic stiffness in this preparation in a manner similar to the volatile anesthetics, the authors suggest that the anesthetics studied by Shibata et al. may well exert a significant component of their negative inotropic activity via their action on the sarcolemmal slow Ca2+ channel.
Advances in Experimental Medicine and Biology | 1991
Michael R. Berman; Eugenie S. Casella; Thomas J. J. Blanck
In addition to their general anesthetic effects, the halogenated volatile anesthetics (e.g., halothane, enflurane, isoflurane) are known to significantly depress cardiac contractility. In the late 1960’s, Goldberg and Ullrick1 reported a dose-dependent and reversible depression of twitch force by halothane (as delivered by a calibrated vaporizer) in the range of 0.1% to 2.35%. They argued that “… halothane seems to exert its cardiac effects primarily by decreasing the intensity of the active state. …” In a comparative study of the effects of several general anesthetic agents on cardiac contractility, Brown and Crout2 reported similar results for halothane as well as for methoxyflurane. They, too, suggested that these agents exerted their cardio-depressive effects via a diminution of the active state of cardiac muscle. Although the concept of “active state” is no longer useful, it is known to be associated with the calcium transient; that is, the rapid rise and fall of intracellular free calcium concentration seen subsequent to electrical stimulation.
Anesthesiology | 1991
James L. Robotham; Masao Takata; Michael R. Berman; Yasuhiko Harasawa
Investigative Ophthalmology & Visual Science | 1979
Kenneth R. Kenyon; Michael R. Berman; Jeannette Rose; Janet Gage
Investigative Ophthalmology & Visual Science | 1982
Michael R. Berman; S Winthrop; D Ausprunk; J Rose; Robert Langer; Janet Gage
Investigative Ophthalmology & Visual Science | 1980
Conn H; Michael R. Berman; Kenneth R. Kenyon; Robert Langer; Janet Gage
Investigative Ophthalmology & Visual Science | 1988
Ken Hayashi; G Frangieh; Kenneth R. Kenyon; Michael R. Berman; G Wolf
Journal of Molecular and Cellular Cardiology | 1992
Jon N. Peterson; Michael R. Berman
Collaboration
Dive into the Michael R. Berman's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs